X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (18) 18
humans (15) 15
infectious diseases (14) 14
male (14) 14
female (13) 13
adult (12) 12
hiv infections - drug therapy (11) 11
clinical trials (9) 9
middle aged (9) 9
antiretroviral drugs (8) 8
hiv (8) 8
human immunodeficiency virus--hiv (8) 8
microbiology (8) 8
pharmacology & pharmacy (7) 7
protease inhibitors (7) 7
treatment outcome (7) 7
antiretroviral therapy (6) 6
immunology (6) 6
anti-hiv agents - adverse effects (5) 5
double-blind (5) 5
prospective studies (5) 5
virology (5) 5
analysis (4) 4
anti-hiv agents - administration & dosage (4) 4
anti-hiv agents - therapeutic use (4) 4
hiv infections - virology (4) 4
hiv protease inhibitors - therapeutic use (4) 4
medication adherence (4) 4
retrospective studies (4) 4
ritonavir (4) 4
viral load (4) 4
aids/hiv (3) 3
antiretroviral agents (3) 3
comparative analysis (3) 3
drug therapy, combination (3) 3
drug-related side effects and adverse reactions - epidemiology (3) 3
efavirenz (3) 3
heterocyclic compounds, 3-ring - adverse effects (3) 3
heterocyclic compounds, 3-ring - therapeutic use (3) 3
hiv infection (3) 3
hiv infections - prevention & control (3) 3
hiv integrase inhibitors - therapeutic use (3) 3
hiv-1 - drug effects (3) 3
lopinavir/ritonavir (3) 3
once-daily dolutegravir (3) 3
post-exposure prophylaxis - methods (3) 3
risk factors (3) 3
ritonavir - therapeutic use (3) 3
tenofovir (3) 3
therapy (3) 3
acute disease (2) 2
adherence (2) 2
adolescents (2) 2
adults (2) 2
anti-retroviral agents - adverse effects (2) 2
anti-retroviral agents - therapeutic use (2) 2
antiretroviral therapy, highly active - adverse effects (2) 2
antiretroviral therapy, highly active - methods (2) 2
antiviral agents (2) 2
care and treatment (2) 2
chemoprevention - adverse effects (2) 2
chemoprevention - methods (2) 2
cholesterol (2) 2
cohort studies (2) 2
combination (2) 2
comorbidity (2) 2
dolutegravir (2) 2
dosage and administration (2) 2
drug therapy (2) 2
efficacy (2) 2
emtricitabine (2) 2
emtricitabine - therapeutic use (2) 2
epidemiology (2) 2
genotype & phenotype (2) 2
hepatitis c - drug therapy (2) 2
hepatitis c - epidemiology (2) 2
hiv infections - complications (2) 2
hiv infections - epidemiology (2) 2
hiv integrase inhibitors - adverse effects (2) 2
hiv patients (2) 2
hiv protease inhibitors - adverse effects (2) 2
hiv-1 (2) 2
hiv-1 - isolation & purification (2) 2
hiv-1-infected patients (2) 2
hiv-infected patients (2) 2
human-immunodeficiency-virus (2) 2
incidence (2) 2
infection (2) 2
inhibitors (2) 2
initial treatment (2) 2
integrase (2) 2
lamivudine (2) 2
lipids (2) 2
maraviroc (2) 2
medicine, general & internal (2) 2
men (2) 2
monotherapy (2) 2
motivation (2) 2
open-label (2) 2
pharmacokinetics (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the International AIDS Society, ISSN 1758-2652, 10/2016, Volume 19, Issue 8(Suppl 7), pp. 21487 - n/a
Journal Article
AIDS, ISSN 0269-9370, 10/2019, Volume 33, Issue 12, pp. 1891 - 1896
BACKGROUND:There is an increasing interest in two-drug regimens. We hypothesized that maintenance therapy with raltegravir and lamivudine would keep HIV-1... 
Journal Article
Journal Article
by Cahn, Pedro and Madero, Juan Sierra and Arribas, José Ramón and Antinori, Andrea and Ortiz, Roberto and Clarke, Amanda E and Hung, Chien-Ching and Rockstroh, Jürgen K and Girard, Pierre-Marie and Sievers, Jörg and Man, Choy and Currie, Alexander and Underwood, Mark and Tenorio, Allan R and Pappa, Keith and Wynne, Brian and Fettiplace, Anna and Gartland, Martin and Aboud, Michael and Smith, Kimberly and Cassetti, Lidia and David, Daniel and Figueras, Laura and Losso, Marcelo and Lopardo, Gustavo and Lupo, Sergio and Porteiro, Norma and Sánchez, Marisa and Bloch, Mark and Cooper, David and Finlayson, Robert and Kelleher, Anthony and Koh, Kenneth and Lewis, David and McMahon, James and Moore, Richard and Roth, Norman and Shields, Matthew and De Wit, Stephane and Florence, Eric and Goffard, Jean-Christophe and Demeester, Remy and Lacor, Patrick and Vandercam, Bernard and Vandekerckhove, Linos and Angel, Jonathan and Baril, Jean-Guy and Conway, Brian and De Pokomandy, Alexandra and Szabo, Jason and Walmsley, Sharon and Bouchaud, Olivier and Chidiac, Christian and Delobel, Pierre and Goujard, Cecile and Katlama, Christine and Molina, Jean-Michel and Pialoux, Gilles and Philibert, Patrick and Bogner, Johannes and Esser, Stefan and Krznaric, Ivanka and Lehmann, Clara and Spinner, Christoph and Stellbrink, Hans-Jurgen and Stephan, Christoph and Stoehr, Albrecht and Barchi, Enrico and Caramello, Pietro and Castelli, Francesco and Cattelan, Anna Maria and D'Arminio Monforte, Antonella and Di Biagio, Antonio and Di Perri, Giovanni and Gori, Andrea and Maggiolo, Franco and Menzaghi, Barbara and Migliorino, Guglielmo and Mussini, Cristina and Penco, Giovanni and Puoti, Massimo and Rizzardini, Giuliano and Gulminetti, Roberto and Lazzarin, Adriano and Quirino, Tiziano and Sighinolfi, Laura and Viale, Pierluigi and Amaya Tapia, Gerardo and Andrade Villanueva, Jaime and Granados Reyes, Enrique R and Perez Rios, Alma and Santoscoy Gomez, Mario and Den Hollander, Jan and Rijnders, Bart and Hidalgo, José A and Hercilla Vasquez, Luis and Illescas, Luis and Olczak, Anita and Mansinho, Kamal and Correia Pacheco, Patricia Paula and ... and GEMINI Study Team
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10167, pp. 143 - 155
Journal Article
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 2016, Volume 71, Issue 7, pp. 1987 - 1993
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
AIDS (London, England), 07/2019
There is an increasing interest in two-drug regimens. We hypothesized that maintenance therapy with raltegravir plus lamivudine would keep HIV-1 suppressed and... 
Journal Article
Journal of the International AIDS Society, ISSN 1758-2652, 01/2014, Volume 17, Issue 1, pp. 19246 - n/a
Introduction Monotherapy with protease‐inhibitors (MPI) may be an alternative to cART for HIV treatment. We assessed the impact of this strategy on immune... 
microbial translocation | monocyte | protease inhibitor | monotherapy | immune activation | very low‐level viremia | Immune activation | Monocyte | Microbial translocation | Monotherapy | Very low-level viremia | Protease inhibitor | INFECTIOUS DISEASES | CLINICAL-TRIAL | 50 COPIES/ML | IMMUNOLOGY | CEREBROSPINAL-FLUID | HIV-INFECTED PATIENTS | REVERSE-TRANSCRIPTASE INHIBITORS | DARUNAVIR/RITONAVIR MONOTHERAPY | ACTIVE ANTIRETROVIRAL THERAPY | MONET TRIAL | very low-level viremia | Cross-Sectional Studies | Viremia | GPI-Linked Proteins - analysis | Humans | Middle Aged | Receptors, Cell Surface - analysis | Male | Monocytes - immunology | Inflammation - epidemiology | Bacterial Translocation | HIV Protease Inhibitors - therapeutic use | Lipopolysaccharide Receptors - analysis | Antigens, CD - analysis | CD4-Positive T-Lymphocytes - immunology | Monocytes - chemistry | HIV Infections - immunology | Receptors, IgG - analysis | Antigens, Differentiation, Myelomonocytic - analysis | Blood Coagulation | HIV Infections - complications | Adult | Female | HIV Infections - drug therapy | CD8-Positive T-Lymphocytes - immunology | Fc receptors | Care and treatment | Protease inhibitors | Patient outcomes | Physiological aspects | Development and progression | Inflammation | Research | Studies | Flow cytometry | Antiretroviral drugs | Lymphocytes | Human immunodeficiency virus--HIV | Blood tests | Clinical trials | Inhibidors enzimàtics | Antiretrovirals | Limfòcits | Enzyme inhibitors | Translocation (Genetics) | Antiretroviral agents | Translocació (Genètica) | VIH (Virus) | HIV (Viruses)
Journal Article